Large intestinal (colorectal) cancer screening by Vassallo, Pierre
the large intestine is composed of the colon and rectum and is the third most common site of cancer in the body. Colorectal cancer affects both males and females equally and is the 
second most common cause of death from cancer. 
Screening for colorectal cancer can reduce deaths from this 
condition significantly.1 The aim of screening is to detect pre-
cancerous/cancer-prone lesions before they become malignant. 
Screening methods include Faecal Occult Blood Testing 
(FOBT), Double Contrast Barium Enema (DCBE), Computed 
Tomographic Colonography (CTC) and Colonoscopy. 
FOBT looks for blood in the stool, but it has been shown to 
be unreliable as it misses non-bleeding cancers (false negatives) 
and is unable to distinguish cancer from other (non-cancerous) 
causes of intestinal bleeding (false positive).2 
DCBE is an X-ray examination that involves coating the 
large bowel with barium sulphate-based contrast material and 
distending it with air followed by a series of X-ray images to 
view different portions of the colon and rectum (figure 1). DCBE 
has been used for many years and is a reliable tool for detecting 
colorectal cancer, however it has largely been replaced by CTC. 
CTC offers numerous advantages, namely, 3D viewing of the 
colon, detection of disease within the colonic lumen, as well as in 
the colonic wall and beyond , while also viewing potential sites of 
cancer spread (metastasis) particularly the liver and lymph nodes. 
DCBE is also of limited value in those patients in whom bowel 
preparation measures fail to attain adequate bowel cleansing. 
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CTC uses the advantages of Computed Tomography to deliver 
high resolution 3D and cross-sectional images of the large bowel, 
while allowing analysis of all other abdominal and pelvic organs. 
Prior to the examination, bowel cleansing measures are taken in 
order to improve visibility of abnormalities in the bowel wall. Bowel 
preparation usually lasts 2 days, in which laxatives and adequate 
hydration are prescribed using a standard protocol. Just prior to 
the CT examination, a short rectal tube is inserted and the colon is 
insufflated with air or carbon dioxide (CO2); CO2 is preferred as it 
is more rapidly absorbed and results in less discomfort due to bowel 
distention. Adequate bowel distention is confirmed through a 
prior scout image of the abdomen. Subsequently prone and supine 
CT scans using a multi-detector CT scanner (usually 64-slice 
scanners are used) are performed using a thin section technique 
with slices measuring 0.6mm or less in thickness. The supine 
scan is performed with intravenous contrast material injection. 
Electronic cleansing techniques have been developed that increase 
patient comfort and compliance by replacing pre-examination 
bowel preparation regimens; this is achieved by administering oral 
contrast material prior to the exam to label the faecal contents of 
the bowel, which can be subsequently electronically subtracted 
from the CT images. 
CTC exams are reviewed in 3D endoscopic mode (https://
youtu.be/8MiufJNDrU8) and in multi-planar cross-sectional mode. 
The 3D endoscopic mode allows visualisation of that portion of any 
abnormality that protrudes into the bowel, while the cross-sectional 
mode detects extension of disease through and beyond the bowel 
wall. CTC can visualise polyps and measure polyp size (figure 2). 
The extent of bowel wall penetration and local (figure 3) as well as 
distant metastatic disease (figure 4) can also be assessed. 
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Colonoscopy is a procedure that allows visualisation of the 
inner lining of your large intestine. This is done by inserting 
a flexible colonoscope through the anus to look at the colon 
(figure 5). The procedure is performed in an operating theatre 
and usually requires light general anaesthesia. Sometimes 
colonoscopy is performed under sedation, however this is 
frequently not well tolerated by the patient. Prior meticulous 
bowel cleansing is required. Long and tortuous large intestines, 
which are often present in the elderly population, may prevent 
the examiner from viewing the more proximal portions of the 
colon; in this case, one would need to resort to performing a 
CTC. A colonoscopy allows direct visualisation of ulcers, colon 
polyps, tumours, and areas of inflammation or bleeding. During 
a colonoscopy, biopsies can be collected and abnormal growths 
can be taken out. 
CTC has rates of polyp detection comparable to those of 
colonoscopy, and its use in favour of colonoscopy improves 
overall compliance of patients who should have regular 
colorectal cancer screening. It is minimally invasive, requires no 
sedation/anaesthesia, has the potential for reducing the number 
of incomplete examinations (inability to reach the proximal 
colon), and has faster patient throughput.2,3
The aim of any colorectal cancer screening test is to detect 
an advanced adenoma, which is pathologically defined as 
Figure 5: Comparison of images on Colonoscopy (A) 
and CTC 3D endoscopic view (B) showing the same 
colonic lesion.
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Figure 1: DCBE showing in (A) a small polyp (arrow) in the descending colon and in (1B) 
concentric narrowing of the rectum (called an apple-core lesion) (arrows). 
Figure 2: CTC 3D endoscopic view shows a 
sessile polyp (arrow).
Figure 3: Coronal cross-sectional CTC image 
shows two lesions (yellow arrows) in the 
ascending colon with the lower one showing 
extension through the bowel wall. 
Figure 4: Axial cross-sectional CTC image 
shows a primary lesion in the transverse 
colon (white arrow) and a metastatic lesion 
in the liver (black arrow).
a lesion that is 10 mm or larger, has villous features, or has 
high-grade cellular dysplasia. Lesions smaller than 6 mm are 
often hyperplastic with no malignant potential. Adenomatous 
polyps that are 5 mm or smaller have a slow growth rate and 
a low incidence of dysplasia, and both CTC and colonoscopy 
have low sensitivity for depicting them. A reporting protocol 
for CTC known as the CT colonography-Reporting and Data 
System (C-RADS) recommends that these lesions should not 
be reported in view of the fact that the risk for malignancy 
in adenomatous polyps that are 5 mm or smaller is estimated 
to be much less than 1%.4 C-RADS recommends short-term 
surveillance for patients with one or two 6–9-mm polyps and no 
additional risk factors, although there is continued debate and 
research relating to the appropriate polyp size and number to 
determine whether to either opt for colonoscopy and biopsy or 
for a surveillance strategy. 
The aim of colorectal cancer screening is to detect 
precancerous polyps and to remove them before they turn into 
cancer. Screening also helps to find colon cancer at an early 
stage, when treatment often leads to a cure. The incidence of 
colorectal cancer rises after 50 years of age. So after turning 50 
or if experiencing abnormal bowel symptoms (such as an altered 
bowel habit or blood in the stools), one should get screened 
without delay. Colon cancer screening saves lives.  
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